Women are underrepresented in trials for conditions that predominately affect them

Historically, female participants have been underrepresented in clinical trials as medical research has been more focused on male health. Studies have shown that this lack of female inclusion correlates to suboptimal health care and adverse medical outcomes for women. Closing the gender health gap has become a topic of paramount concern in recent years. Adequate female trial participation is crucial to analyze sex-specific differences in data to prevent women from experiencing poorer health outcomes than men. However, although GlobalData’s clinical trials database has revealed that there are several conditions that disproportionately affect women, the participant demographic is exceedingly male.